These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 31397268)

  • 1. Monthly direct and indirect costs of management of CKD 3 - 5 non-dialysis patients in an out-of-pocket expenditure system: The Case of Yaoundé.
    Ngeugoue FT; Njoumemi Z; Kaze FF
    Clin Nephrol; 2020; 93(1):100-102. PubMed ID: 31397268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures.
    Small C; Kramer HJ; Griffin KA; Vellanki K; Leehey DJ; Bansal VK; Markossian TW
    BMC Nephrol; 2017 Jan; 18(1):3. PubMed ID: 28056852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives.
    Aoun M; Helou E; Sleilaty G; Zeenny RM; Chelala D
    BMC Health Serv Res; 2022 May; 22(1):586. PubMed ID: 35501814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The social cost of chronic kidney disease in Italy.
    Turchetti G; Bellelli S; Amato M; Bianchi S; Conti P; Cupisti A; Panichi V; Rosati A; Pizzarelli F;
    Eur J Health Econ; 2017 Sep; 18(7):847-858. PubMed ID: 27699568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of chronic kidney disease in Korea using national sample cohort.
    Kim SH; Jo MW; Go DS; Ryu DR; Park J
    J Nephrol; 2017 Dec; 30(6):787-793. PubMed ID: 28303461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world costs of autosomal dominant polycystic kidney disease in the Nordics.
    Eriksson D; Karlsson L; Eklund O; Dieperink H; Honkanen E; Melin J; Selvig K; Lundberg J
    BMC Health Serv Res; 2017 Aug; 17(1):560. PubMed ID: 28806944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing key cost drivers associated with caring for chronic kidney disease patients.
    Damien P; Lanham HJ; Parthasarathy M; Shah NL
    BMC Health Serv Res; 2016 Dec; 16(1):690. PubMed ID: 28031020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in healthcare expenditure in United States adults with chronic kidney disease: 2002-2011.
    Ozieh MN; Bishu KG; Dismuke CE; Egede LE
    BMC Health Serv Res; 2017 May; 17(1):368. PubMed ID: 28532412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catastrophic healthcare expenditure and caregiver burden in pediatric chronic kidney disease - a mixed methods study from a low resource setting.
    Reddy S; Scholes-Robertson N; Raj JM; Pais P
    Pediatr Nephrol; 2024 Oct; 39(10):3079-3093. PubMed ID: 38856776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of out-of-pocket costs on treatment commencement and adherence in chronic kidney disease: a systematic review.
    Dodd R; Palagyi A; Guild L; Jha V; Jan S
    Health Policy Plan; 2018 Nov; 33(9):1047-1054. PubMed ID: 30247548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
    Goncalves GMR; Silva END
    PLoS One; 2018; 13(10):e0203992. PubMed ID: 30273345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause costs increase exponentially with increased chronic kidney disease stage.
    Golestaneh L; Alvarez PJ; Reaven NL; Funk SE; McGaughey KJ; Romero A; Brenner MS; Onuigbo M
    Am J Manag Care; 2017 Jun; 23(10 Suppl):S163-S172. PubMed ID: 28978205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global costs attributed to chronic kidney disease: a systematic review.
    Silva Junior GBD; Oliveira JGR; Oliveira MRB; Vieira LJES; Dias ER
    Rev Assoc Med Bras (1992); 2018 Dec; 64(12):1108-1116. PubMed ID: 30569987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.
    Provenzano M; De Francesco M; Iannazzo S; Garofalo C; Andreucci M; Genualdo R; Borrelli S; Minutolo R; Conte G; De Nicola L
    Int J Clin Pract; 2020 May; 74(5):e13475. PubMed ID: 31909866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of patients with chronic kidney disease in Germany.
    Gandjour A; Armsen W; Wehmeyer W; Multmeier J; Tschulena U
    PLoS One; 2020; 15(4):e0231375. PubMed ID: 32330140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study.
    Essue BM; Wong G; Chapman J; Li Q; Jan S
    BMC Nephrol; 2013 Jan; 14():5. PubMed ID: 23305212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of hemodialysis in Jordan.
    Al-Shdaifat EA; Manaf MR
    Indian J Med Sci; 2013; 67(5-6):103-16. PubMed ID: 24326762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
    Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
    [No Abstract]   [Full Text] [Related]  

  • 20. Path Analysis on Medical Expenditures of 855 Patients with Chronic Kidney Disease in a Hospital in Beijing.
    Liu X; Mao YH; Wang HT; Chen XG; Zhao B; Sun Y
    Chin Med J (Engl); 2018 Jan; 131(1):25-31. PubMed ID: 29271376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.